Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wiley

Showing results (581-590 of 619) with videos related to

Pageof 62
Sort By:
Journal of the National Cancer Institute|October 21, 2004
Ductal lavage findings in women with known breast cancer undergoing mastectomySeema A Khan, Elizabeth L Wiley, Norma Rodriguez, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levelsDaniel K Nomura, Carolyn S S Hudak, Anna M Ward, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2016
Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro AssaysT W Grim, A J Morales, M M Gonek, et al.
Journal of Virology|February 28, 2002
Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteinsJames M Binley, Rogier W Sanders, Aditi Master, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2009
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivoJonathan Z Long, Daniel K Nomura, Robert E Vann, et al.
Pharmacology, Biochemistry, and Behavior|April 6, 2020
In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018Thomas F Gamage, Daniel G Barrus, Richard C Kevin, et al.
Behavioural Pharmacology|March 8, 2014
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569Thomas F Gamage, Bogna M Ignatowska-Jankowska, Jenny L Wiley, et al.
Breast Cancer Research and Treatment|July 23, 2020
Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapyArkadiusz Z Dudek, Li C Liu, James H Fischer, et al.
Cancer Research|January 25, 2005
Perinucleolar compartment prevalence has an independent prognostic value for breast cancerRajesh V Kamath, Ann D Thor, Chen Wang, et al.
British Journal of Pharmacology|November 15, 2005
New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosisAlessia Ligresti, Maria Grazia Cascio, Gareth Pryce, et al.
Pageof 62

Showing results (581-590 of 619) with videos related to

Sort By:
Pageof 62
Journal of the National Cancer Institute|October 21, 2004
Ductal lavage findings in women with known breast cancer undergoing mastectomySeema A Khan, Elizabeth L Wiley, Norma Rodriguez, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levelsDaniel K Nomura, Carolyn S S Hudak, Anna M Ward, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2016
Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro AssaysT W Grim, A J Morales, M M Gonek, et al.
Journal of Virology|February 28, 2002
Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteinsJames M Binley, Rogier W Sanders, Aditi Master, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2009
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivoJonathan Z Long, Daniel K Nomura, Robert E Vann, et al.
Pharmacology, Biochemistry, and Behavior|April 6, 2020
In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018Thomas F Gamage, Daniel G Barrus, Richard C Kevin, et al.
Behavioural Pharmacology|March 8, 2014
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569Thomas F Gamage, Bogna M Ignatowska-Jankowska, Jenny L Wiley, et al.
Breast Cancer Research and Treatment|July 23, 2020
Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapyArkadiusz Z Dudek, Li C Liu, James H Fischer, et al.
Cancer Research|January 25, 2005
Perinucleolar compartment prevalence has an independent prognostic value for breast cancerRajesh V Kamath, Ann D Thor, Chen Wang, et al.
British Journal of Pharmacology|November 15, 2005
New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosisAlessia Ligresti, Maria Grazia Cascio, Gareth Pryce, et al.
Pageof 62